Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
astrazeneca
3
×
biogen
3
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
3
×
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
3
×
texas top stories
wisconsin blog main
wisconsin top stories
allergan
boston top stories
bristol-myers squibb
cancer
cancer immunotherapy
eli lilly
ipo
martin shkreli
novartis
What
bio
roundup
biotech
acquisitions
alzheimer’s
announced
annual
assessed
attention
august
busy
ceo
collabs
communities
conference
covid
daniel
days
deal
decisions
devices
drug
drugs
esmo
europe
fda
germany
gilead
gilead’s
help
hosted
introduce
investment
ipo
legacy
medicines
month
munich
news
nods
Language
unset
Current search:
astrazeneca
×
abbvie
×
" texas blog main "
×
biogen
×
national
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More